Skip to main content
Equibles
HUM logo

HUM · Humana Inc · Metrics

Track HUM — free

Use HUM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HUM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$409.80 +9.07 (+2.26%) At close · Sep 11
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$49.20B
Shares
120.06M

HUM metrics

96 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$409.80
Market cap
$49.20B

Price action

20 metrics
Price change (1W)
+2.1%
Price change (30D)
+5.3%
Price change (3M)
+8.1%
Price change (6M)
+147.7%
Price change (YTD)
+60.0%
Price change (1Y)
+47.0%
Trailing year
Price change (5Y)
+1.9%
52-week high
$409.80
52-week low
$163.67
Change from 52-week high
+0.0%
Change from 52-week low
+150.4%
Annualized volatility
47.2%
Annualized volatility (3M)
33.8%
Beta
0.5
RSI (14D)
63.3
Price vs SMA 50
+5.3%
Price vs SMA 200
+44.7%
Avg volume (3M)
1.33M
Relative volume
0.5
Average dollar volume
$508.20M

Company

3 metrics
Sector
Healthcare
Industry
Healthcare Plans
Shares outstanding
120.06M

Valuation

12 metrics
P / E (TTM)
43.7
Trailing earnings · reciprocal yield 2.3%
PEG ratio
—
EV / revenue
0.3×
reciprocal yield 332.8%
EV / EBITDA
13.2×
reciprocal yield 7.6%
EV / EBIT
16.9×
reciprocal yield 5.9%
P / sales
0.4×
reciprocal yield 278.9%
P / book
2.6
reciprocal yield 37.8%
FCF yield
2.6%
TTM · current market cap
Buyback yield
0.5%
P / FCF
38.7
reciprocal yield 2.6%
P / operating cash flow
26.7
reciprocal yield 3.7%
Earnings yield
2.3%

Historical valuation

8 metrics
P / E historical average (3Y)
22.2×
reciprocal yield 4.5%
P / E historical average (5Y)
21.9×
reciprocal yield 4.6%
EV / revenue historical average (3Y)
0.2×
reciprocal yield 413.8%
EV / revenue historical average (5Y)
0.4×
reciprocal yield 262.1%
EV / EBIT historical average (3Y)
8.2×
reciprocal yield 12.3%
EV / EBIT historical average (5Y)
10.9×
reciprocal yield 9.2%
EV / EBITDA historical average (3Y)
6.2×
reciprocal yield 16.0%
EV / EBITDA historical average (5Y)
6.2×
reciprocal yield 16.0%

Dividends & buybacks

7 metrics
Dividend yield
0.9%
Trailing 12 months
Payout ratio
38.0%
Shareholder yield
1.4%
Dividend / share (TTM)
$3.54
Dividend growth YoY
+0.0%
Dividend growth streak
—
Last ex-dividend
2026-06-26

Earnings calendar

2 metrics
Next earnings
2026-11-06
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
—
Operating margin
1.8%
Trailing 12 months
Net margin
0.8%
Gross profit (TTM)
—
Operating profit (TTM)
$2.44B
Net income (TTM)
$1.13B
Trailing 12 months
Diluted EPS (TTM)
$9.37
FCF margin
0.9%
Effective tax rate
17.8%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$154.75

Growth

11 metrics
Revenue growth YoY
+23.5%
Year over year
Net income growth YoY
-4.7%
Revenue (TTM)
$137.20B
Trailing 12 months
EPS growth YoY
-4.6%
Shares change YoY
-0.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+11.8%
Revenue CAGR (5Y)
+10.9%
EPS CAGR (3Y)
-23.6%
EPS CAGR (5Y)
-17.2%
FCF CAGR (3Y)
-52.3%
FCF CAGR (5Y)
-39.6%

Quality

14 metrics
Return on equity
6.1%
Return on assets
2.0%
Debt / equity
0.8
Current ratio
1.8
EBITDA (TTM)
$3.12B
Free cash flow (TTM)
$1.27B
Quick ratio
1.8
Interest coverage
3.7
Net debt / EBITDA
-2.6
Return on invested capital
18.9%
Trailing 12 months
Net cash
$7.97B
Latest balance sheet
Cash & equivalents
$4.95B
Total assets
$55.28B
Total debt
$13.99B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.84B
Capital expenditures (TTM)
$572.00M
R&D (TTM)
—
SG&A (TTM)
$16.09B
Stock compensation (TTM)
$243.00M
R&D / revenue
—
Stock compensation / revenue
0.2%

Ownership (13F)

3 metrics
13F filers
937
13F filer change QoQ
+143
Institutional ownership
104.5%

Short interest

3 metrics
Short interest
2.6%
Latest settlement · 3.1 days to cover
Days to cover
3.1d
Short-squeeze score
47 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 49071 CUSIP 444859102 13F (30d) 216 filings 212 filers Visit website Investor relations